Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125270381 | 12527038 | 1 | I | 20150306 | 20160701 | 20160705 | 20160705 | EXP | GB-MHRA-EYC 00141532 | GB-GLAXOSMITHKLINE-GB2016094606 | GLAXOSMITHKLINE | 49.00 | YR | F | Y | 0.00000 | 20160705 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125270381 | 12527038 | 1 | SS | Atracurium | ATRACURIUM | 1 | Intravenous (not otherwise specified) | 40 MG, UNK | Y | 0 | 40 | MG | |||||||
| 125270381 | 12527038 | 2 | PS | CEFUROXIME. | CEFUROXIME | 1 | Intravenous (not otherwise specified) | 1.5 G, UNK | Y | 50605 | 1.5 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125270381 | 12527038 | 1 | General anaesthesia |
| 125270381 | 12527038 | 2 | Antibiotic prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125270381 | 12527038 | LT |
| 125270381 | 12527038 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125270381 | 12527038 | Anaphylactic reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125270381 | 12527038 | 1 | 20150306 | 20150306 | 0 | |
| 125270381 | 12527038 | 2 | 20150306 | 20150306 | 0 |